|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ji P, Gong Y, Jin ML, Hu X, Di GH and Shao
ZM: The burden and trends of breast cancer from 1990 to 2017 at the
global, regional, and national levels: Results from the global
burden of disease study 2017. Front Oncol. 10:6502020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heer E, Harper A, Escandor N, Sung H,
McCormack V and Fidler-Benaoudia MM: Global burden and trends in
premenopausal and postmenopausal breast cancer: A population-based
study. Lancet Glob Health. 8:e1027–e1037. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fiddes JC and Goodman HM: The gene
encoding the common alpha subunit of the four human glycoprotein
hormones. J Mol Appl Genet. 1:3–18. 1981.PubMed/NCBI
|
|
5
|
Watkins PC, Eddy R, Beck AK, Vellucci V,
Leverone B, Tanzi RE, Gusella JF and Shows TB: DNA sequence and
regional assignment of the human follicle-stimulating hormone
beta-subunit gene to the short arm of human chromosome 11. DNA.
6:205–212. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rivera RT, Pasion SG, Wong DT, Fei YB and
Biswas DK: Loss of tumorigenic potential by human lung tumor cells
in the presence of antisense RNA specific to the ectopically
synthesized alpha subunit of human chorionic gonadotropin. J Cell
Biol. 108:2423–2434. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bièche I, Latil A, Parfait B, Vidaud D,
Laurendeau I, Lidereau R, Cussenot O and Vidaud M: CGA gene (coding
for the alpha subunit of glycoprotein hormones) overexpression in
ER alpha-positive prostate tumors. Eur Urol. 41:335–341. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li YL, Yang TS, Ruan WM, Cui W, Jin Y and
Zou XM: Effect of trichostatin a on SGC-7901 gastric cancer cells.
Int J Clin Exp Med. 7:1958–1966. 2014.PubMed/NCBI
|
|
9
|
Bieche I, Parfait B, Le Doussal V, Olivi
M, Rio MC, Lidereau R and Vidaud M: Identification of CGA as a
novel estrogen receptor-responsive gene in breast cancer: An
outstanding candidate marker to predict the response to endocrine
therapy. Cancer Res. 61:1652–1658. 2001.PubMed/NCBI
|
|
10
|
Bièche I, Parfait B, Noguès C, Andrieu C,
Vidaud D, Spyratos F, Lidereau R and Vidaud M: The CGA gene as new
predictor of the response to endocrine therapy in ER alpha-positive
postmenopausal breast cancer patients. Oncogene. 20:6955–6959.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Del Mastro L, Ceppi M, Poggio F, Bighin C,
Peccatori F, Demeestere I, Levaggi A, Giraudi S, Lambertini M,
D'Alonzo A, et al: Gonadotropin-releasing hormone analogues for the
prevention of chemotherapy-induced premature ovarian failure in
cancer women: Systematic review and meta-analysis of randomized
trials. Cancer Treat Rev. 40:675–683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blumenfeld Z: Fertility preservation and
GnRHa for chemotherapy: Debate. Cancer Manag Res. 6:313–315. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Day EK, Sosale NG and Lazzara MJ: Cell
signaling regulation by protein phosphorylation: A multivariate,
heterogeneous, and context-dependent process. Curr Opin Biotechnol.
40:185–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Walker RA: Significance of alpha-subunit
HCG demonstrated in breast carcinomas by the immunoperoxidase
technique. J Clin Pathol. 31:245–249. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou J, Chen Y, Huang Y, Long J, Wan F and
Zhang S: Serum follicle-stimulating hormone level is associated
with human epidermal growth factor receptor type 2 and Ki67
expression in post-menopausal females with breast cancer. Oncol
Lett. 6:1128–1132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wee P and Wang Z: Epidermal growth factor
receptor cell proliferation signaling pathways. Cancers (Basel).
9:522017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lawlor MA and Alessi DR: PKB/Akt: A key
mediator of cell proliferation, survival and insulin responses? J
Cell Sci. 114:2903–2910. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xunyi Y, Zhentao Y, Dandan J and Funian L:
Clinicopathological significance of PTPN12 expression in human
breast cancer. Braz J Med Biol Res. 45:1334–1340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Espejo R, Rengifo-Cam W, Schaller MD,
Evers BM and Sastry SK: PTP-PEST controls motility, adherens
junction assembly, and Rho GTPase activity in colon cancer cells.
Am J Physiol Cell Physiol. 299:C454–C463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun T, Aceto N, Meerbrey KL, Kessler JD,
Zhou C, Migliaccio I, Nguyen DX, Pavlova NN, Botero M, Huang J, et
al: Activation of multiple proto-oncogenic tyrosine kinases in
breast cancer via loss of the PTPN12 phosphatase. Cell.
144:703–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Villa-Moruzzi E: Tyrosine phosphatases in
the HER2-directed motility of ovarian cancer cells: Involvement of
PTPN12, ERK5 and FAK. Anal Cell Pathol (Amst). 34:101–112. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Villa-Moruzzi E: PTPN12 controls PTEN and
the AKT signalling to FAK and HER2 in migrating ovarian cancer
cells. Mol Cell Biochem. 375:151–157. 2013.PubMed/NCBI
|
|
27
|
Singletary SE and Greene FL; Breast Task
Force, : Revision of breast cancer staging: The 6th edition of the
TNM Classification. Semin Surg Oncol. 21:53–59. 2003. View Article : Google Scholar : PubMed/NCBI
|
